指南与共识复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

重症患者血管升压药与正性肌力药使用的良好临床实践:最新进展与专家共识

Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus.
指南 / 共识 · Minerva Anestesiol · 2021-01-12
一句话结论意大利麻醉与重症监护学会(SIAARTI)专家共识:针对脓毒症休克与心源性休克,就血管升压药和正性肌力药的使用提出29个临床问题,专家组成员对适用性达成高度一致。

该共识由意大利麻醉与重症监护学会(SIAARTI)推动,旨在为重症患者血管升压药与正性肌力药的使用及休克管理提供良好临床实践指导。研究组建了16位重症医学与血流动力学专家小组,基于PICO问题系统检索文献,采用改良半定量RAND/UCLA适用性方法评估特定临床场景的适用性。小组针对脓毒症休克与心源性休克患者使用血管升压药和正性肌力药确定了29个临床问题,专家组成员对这些药物在两类休克患者中使用的适用性达成高度一致。原文未报告具体的推荐条款、药物剂量及推荐等级。

要点

  • SIAARTI专家共识聚焦重症患者血管升压药与正性肌力药的良好临床实践,覆盖脓毒症休克与心源性休克两类场景。
  • 小组由16位重症医学与血流动力学专家组成,基于PICO问题系统检索文献并采用改良半定量RAND/UCLA适用性方法。
  • 共确定29个关于脓毒症休克与心源性休克患者使用血管升压药和正性肌力药的临床问题。
  • 专家组成员对正性肌力药/血管升压药在脓毒症休克与心源性休克患者中使用的适用性达成高度一致。

适用人群与场景

  • 重症患者,具体为脓毒症休克与心源性休克患者。

研究设计与关键结果

  • SIAARTI推动项目,成立16位重症医学与血流动力学专家小组,基于PICO问题系统检索文献,采用改良半定量RAND/UCLA适用性方法评估临床场景适用性,确定29个关于脓毒症休克与心源性休克患者使用血管升压药和正性肌力药的临床问题,专家组成员对适用性达成高度一致。

证据类型、等级与局限

  • 证据类型:专家共识(SIAARTI),采用系统文献回顾与改良半定量RAND/UCLA适用性方法。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出具体推荐。

指南或共识出处

  • Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus,意大利麻醉与重症监护学会(SIAARTI),发表于Minerva Anestesiol。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Vasopressors and inotropic agents are widely used in critical care. However, strong evidence supporting their use in critically ill patients is lacking in many clinical scenarios. Thus, the Italian Society of Anesthesia and Intensive Care (SIAARTI) promoted a project aimed to provide indications for good clinical practice on the use of vasopressors and inotropes, and on the management of critically ill patients with shock. A panel of 16 experts in the field of intensive care medicine and hemodynamics has been established. Systematic review of the available literature was performed based on PICO questions. Basing on available evidence, the panel prepared a summary of evidence and then wrote the clinical questions. A modified semi-quantitative RAND/UCLA appropriateness method has been used to determine the appropriateness of specific clinical scenarios. The panel identified 29 clinical questions for the use of vasopressors and inotropes in patients with septic shock and cardiogenic shock. High level of agreement exists among the panel members about appropriateness of inotropes/vasopressors' use in patients with septic shock and cardiogenic shock.

来源:Minerva Anestesiol,查看原文。版权归原作者所有。

参考来源

  1. Carsetti A, Bignami E, Cortegiani A, et al. Good clinical practice for the use of vasopressor and inotropic drugs in critically ill patients: state-of-the-art and expert consensus. Minerva Anestesiol. 2021. PMID: 33432794. doi:10.23736/S0375-9393.20.14866-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。